Austin, TX · Founded 2021 · Privately Held (backing)
Operator of a bioscience and genetic engineering company developing technologies to advance genomics. Colossal Biosciences is based in Austin, TX and was founded in 2021. It was valued at $10.3 billion at its later-stage round in Sep 2025, the last priced event on record. It has raised $558 million across 1 recorded round; the latest was a $163 million later-stage round in Jan 2023.
PMV mark · valuation
$10.3B
Oct 2026
Priced at
its later-stage round
Sep 2025
Total raised
$557.6M
Last round
Later Stage VC
Jan 2023
No prints on record
No secondary trades in Colossal Biosciences shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Colossal Biosciences with a free account
·The complete investor list: 51 names
·Watch Colossal Biosciences: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Colossal Biosciences stock.
